cbdMD, Inc. Income Statement

Income Statement Sep2016 Sep2017 Sep2018 Sep2019 Sep2020 Sep2021 Sep2022 Sep2023 Sep2024 Sep2025
Revenue & cost
Revenue 2.03M4.47M0.46M23.65M41.88M47.33M37.12M25.05M19.92M19.19M
Cost of Revenue 1.62M1.36M0.10M9.14M15.51M14.50M13.07M9.18M7.49M7.22M
Gross Profit 0.41M3.12M0.36M14.51M26.37M29.99M22.34M14.98M12.00M11.97M
Operating items
Restructuring Costs 0.60M
Other Operating Expenses 4.15M3.36M-2.62M-51.69M43.95M49.60M0.09M
Operating Expenses 4.15M3.36M2.15M29.31M43.95M49.60M0.60M
Operating Income -3.89M-1.36M-1.80M-14.80M-17.58M-19.62M-78.27M-22.49M-3.32M-2.16M
EBIT -3.89M-1.36M-1.80M-14.80M-17.58M-19.62M-78.27M-22.49M-3.32M-2.16M
Non-operating items
Non Operating Investment Income -0.10M-0.17M0.55M-0.03M-0.70M
Other Non Operating Income 1.47M0.24M
Non Operating Income 0.03M0.24M
Net income details
EBT -4.04M-1.86M-1.80M-47.79M12.65M-24.29M-70.08M-22.94M-3.70M-2.04M
Tax Provisions 0.01M0.03M-2.36M1.35M-0.90M
Profit After Tax -3.90M-1.39M-1.80M-51.36M12.65M-23.39M-70.08M-22.94M-3.70M-2.04M
Income from Non-Controlling Interests 0.47M-0.93M
Income from Continuing Operations -4.05M-1.89M-1.80M-45.43M11.31M-23.39M-70.08M-22.94M-3.70M-2.04M
Consolidated Net Income -4.05M-1.89M1.86M-5.93M-0.05M-23.39M-70.08M-22.94M-3.70M-2.04M
Income towards Parent Company -4.05M-1.89M1.86M-5.93M-0.05M-23.39M-70.08M-22.94M-3.70M-2.04M
Preferred Dividend Payments 0.37M2.55M4.00M4.00M4.00M2.33M
Net Income towards Common Stockholders -3.36M-1.74M-0.41M-50.43M12.24M-25.95M-74.09M-26.94M-7.70M-4.38M
Additional items
EPS (Basic) -1.13-0.38-0.23-2.820.28-0.47-1.24-75.48-16.38-0.49
EPS (Weighted Average and Diluted) -0.05-2.820.28-0.47
Shares Outstanding (Weighted Average) 0.02M0.03M0.08M0.14M0.16M0.17M0.36M0.47M8.91M
Shares Outstanding (Diluted Average) 7.75M17.89M45.17M54.94M
EBITDA -3.89M-1.36M-1.80M-14.80M-17.58M-19.62M-78.27M-22.49M-3.32M-2.16M
Interest Expenses 0.15M0.50M955.00
Tax Rate 4.94%10.63%3.68%